Sign up
Quantellect · Congress · Trade Detail
CELGCelgene Corporation (CELG)
RepublicanHouse

James B. Renacci sold Celgene Corporation (CELG) (CELG)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 39 trades in Celgene Corporation (CELG) (CELG) since 2013, 18 purchases and 21 sales, worth an estimated $459K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of Celgene Corporation (CELG) (CELG) on December 30, 2013. Since that trade, CELG is up +0.00% against the S&P 500 up +388.56%, an outperformance of -388.56%.

Across these filings, James B. Renacci has been a net seller of CELG (a buy-to-sell ratio of 0.86). The most recent disclosed CELG transaction shown was dated July 20, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CELG trades
39
Disclosed Vol
$459K
Buys
18
46%
Sells
21
54%
Buy / Sell
0.86
ratio
First → Last
2013–2016

James B. Renacci's CELG trades vs the price

CELG is up +0.00% since James B. Renacci sold on December 30, 2013, versus +388.56% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+388.56%
Outperformance vs S&P 500
-388.56%

All James B. Renacci CELG trades

TradedTypeSizeReturnEst. profit
July 20, 2016SELL$15,001 - $50,000N/A
March 14, 2016SELL$1,001 - $15,000N/A
March 14, 2016BUY$15,001 - $50,000N/A
February 18, 2016BUY$1,000 - $15,000N/A
February 12, 2016SELL$1,000 - $15,000N/A
January 27, 2016SELL$1,000 - $15,000N/A
January 26, 2016SELL$1,000 - $15,000N/A
January 21, 2016SELL$1,000 - $15,000N/A
December 7, 2015SELL$1,000 - $15,000N/A
September 30, 2015BUY$1,000 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & CELG trading FAQ

Is it legal for James B. Renacci to trade Celgene Corporation (CELG) (CELG) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Celgene Corporation (CELG) (CELG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell CELG?

James B. Renacci disclosed a sale of $1,000 - $15,000 of Celgene Corporation (CELG) (CELG) on December 30, 2013, according to public STOCK Act filings.

How has CELG performed since James B. Renacci's trade?

Since James B. Renacci sold CELG on December 30, 2013, the stock is up +0.00%, versus +388.56% for the S&P 500 over the same period, an outperformance of -388.56%.

How many times has James B. Renacci traded CELG?

James B. Renacci has disclosed 39 CELG trades since 2013 (18 purchases and 21 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CELG trades?

Quantellect tracks every disclosed congressional trade in Celgene Corporation (CELG) (CELG) on the Celgene Corporation (CELG) congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's CELG tradesAll congressional filings for Celgene Corporation (CELG)James B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.